The University of Hong Kong
Hong Kong
Location status: Recruiting
Location contact
JACKY CP CHOY, Philosophy of Doctor
CONTACT
Shiyu LU, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07544875
The goal of this mixed method clinical trial is to evaluate whether BrainLive Coach training can enhance knowledge, skills, and wellbeing among young old volunteers.
The main question it aims to answer are:
• Do trained BrainLive Coaches demonstrate greater CST-related knowledge/skills, self-efficacy, and improved quality of life compared with volunteers receiving only educational materials?
Researchers will compare the BrainLive Coach training group vs. general service group (young old volunteers) to see whether the intervention leads to enhanced dementia knowledge, sense of competence in dementia care, and approaches to dementia.
Participants will be:
1. Adults aged 50 and over - volunteers (nRCT)
* Participate in either 80-90 hours of BrainLive Coach training followed by volunteering in BrainLive Connect or receive educational materials on dementia and cognitive health. * Complete assessments at baseline (T0) and post intervention (T1) on dementia knowledge, competence in dementia care, self-efficacy, attitudes to dementia, quality of life, and social capital. 2. Qualitative study participants • Take part in individual interviews or focus groups, including trained volunteers, and NGO staff, to explore perceived impacts, mechanisms, implementation facilitators/barriers, and areas for improvement.
Interested in participating?
Request Info50 year and older
All sexes
Interventional
Not applicable
Hong Kong
Location status: Recruiting
JACKY CP CHOY, Philosophy of Doctor
CONTACT
Shiyu LU, PhD
PRINCIPAL_INVESTIGATOR
The research design is a non-randomized controlled trial (nRCT), involving 90 healthy adults aged 50 and over in the experimental group (Training group) who will receive 80-90 hours of BrainLive Coach Training, and another 90 young-old in the control group (Education group) who will receive educational workshops for comparison. Data will be collected at two time points: baseline (T0) and after the completion of BrainLive Connect volunteering (T1). Participants in the control group (N=90) will be recruited from the HKU network. During the evaluation period, control group participants will attend educational workshops focused on dementia and cognitive health.
The BrainLive Coach training aims to enhance the skills and knowledge for delivering evidence-based dementia intervention (Primary outcomes); and improve self-efficacy, quality of life, and social capital of the young-old individuals. The outcome measures include Dementia Knowledge Assessment Tool, Sense of Competence in Dementia Care, Approaches to Dementia, General Self-efficacy scale, Quality of Life and social capital assessment tool.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Unable to communicate and participate in interviews/training/intervention due to hearing impairment, visual impairment, or other conditions.
Volunteers will be trained, supervised and supported to deliver one of three modes of CST (Exercise-enhanced CST, Home2Community CST, Living CST). Basic level training covering topics fundamental to dementia education and common across different CST modes to all recruited volunteers; and then advanced level training covering knowledge and skills specific to each CST mode and service settings.
Volunteers will receive dementia-related educational materials
Time frame: Baseline (T0) and 3 months after start of CST training (T1)
Possible range: 0 - 21, with higher scores indicate better knowledge
Time frame: Baseline (T0) and 3 months after start of CST training (T1)
Possible range: 17 - 68, with higher scores indicate better sense of competence in dementia care
Time frame: Baseline (T0) and 3 months after start of CST training (T1)
Possible range: 19 - 95, with higher scores indicate more positive and person-centered attitude
Time frame: Baseline (T0) and 3 months after start of CST training (T1)
Possible range: 0 - 30, with higher scores indicate greater social support and engagement. A total score of 12 or less is commonly used as a cut-off point to identify individuals at risk for social isolation
Time frame: Baseline (T0) and 3 months after start of CST training (T1)
Possible range: 8 - 40, with higher scores indicate better quality of life
Time frame: Baseline (T0) and 3 months after start of CST training (T1)
Possible range: 10 - 40, with higher scores indicate higher self-efficacy
Time frame: Baseline (T0) and 3 months after start of CST training (T1)
Possible range: 0 - 60, with higher scores indicate more bidirectional social support
Time frame: Baseline (T0) and 3 months after start of CST training (T1)
Possible range: 16 - 80, with higher scores indicate better sense of belonging
Time frame: Baseline (T0) and 3 months after start of CST training (T1)
Possible range: 10 - 70, with higher scores indicate better meaning in life
Time frame: Baseline (T0) and 3 months after start of CST training (T1)
Possible range: 7 - 35, with higher scores indicate better well-being
Time frame: Baseline (T0) and 3 months after start of CST training (T1)
Possible range: 0 - 48, with higher scores indicate higher caregiver burden
Contact information is provided by the study sponsor or research team.
JACKY CP CHOY, PhD
CONTACT
Shiyu LU, PhD
CONTACT
The University of Hong Kong
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02014246
Brain Diseases, Central Nervous System Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT07414680
Aging, Behavior
Taipei, Taiwan
View Trial DetailsNCT07731334
Brain Diseases, Central Nervous System Diseases
Florence, FI, Italy
View Trial DetailsNCT07730957
Aberrant Motor Behavior in Dementia, Behavior
Amiens, France
View Trial Details